BP
OGN icon

BNP Paribas’s Organon & Co OGN Stock Holding History

BNP Paribas’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$568 Sell
95
-90
-49% -$677 ﹤0.01% 325
2025
Q4 		$1.32K Hold
185
– – ﹤0.01% 334
2025
Q3 		$1.95K Buy
185
+90
+95% +$883 ﹤0.01% 320
2025
Q2 		$917 Hold
95
– – ﹤0.01% 333
2025
Q1 		$1.42K Hold
95
– – ﹤0.01% 343
2024
Q4 		$1.42K Hold
95
– – ﹤0.01% 361
2024
Q3 		$1.83K Hold
95
– – ﹤0.01% 353
2024
Q2 		$1.97K Sell
95
-59
-38% -$1.17K ﹤0.01% 321
2024
Q1 		$2.87K Buy
+154
New +$2.64K ﹤0.01% 325

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

BNP Paribas's OGN Position: Q1 2026 in Review

BNP Paribas reduced its Organon & Co (OGN) stake by 49% in Q1 2026, selling an estimated $677 and leaving 95 shares worth $568. The position accounts for ﹤0.01% of the portfolio, ranked #325.

BNP Paribas first reported a position in OGN in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.87K in Q1 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • BNP Paribas held 95 shares of Organon & Co worth $568 as of Q1 2026.
  • BNP Paribas sold 90 Organon & Co shares in Q1 2026, an estimated $677.
  • Organon & Co made up ﹤0.01% of BNP Paribas's portfolio in Q1 2026, its #325 holding.
  • BNP Paribas first reported a position in Organon & Co in Q1 2024 and has held it in 9 quarters since.
  • BNP Paribas's Organon & Co position peaked at $2.87K in Q1 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.